IGF-independent regulation of breast cancer growth by IGF binding proteins

Breast Cancer Research and Treatment

Volumn 47, Issue 3, 1998, Pages 283-293

  Oh, Youngman ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Growth inhibition; IGF binding proteins; IGFBP 3; IGFBP 7

Indexed keywords

ANTIESTROGEN; CELL SURFACE PROTEIN; RETINOIC ACID; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN BINDING PROTEIN 7; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CELL TYPE; HALF LIFE TIME; HUMAN; MITOGENESIS; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; TUMOR CELLS, CULTURED;

EID: 0031985011     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005911319432     Document Type: Article

References (71)

1. Salmon WD, Daughaday WH: A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825-836, 1957
2. Daughaday WH, Hall K, Raben MS, Salmon WD, Van den Brande JLV, Van Wyk JJ: Somatomedin: Proposed designation for sulphation factor. Nature 235:107, 1972
3. Daughaday WH, Rotwein P: Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrine Rev 10:68-91, 1989
4. Rosenfeld RG, Lamson GL, Pham H, Oh Y, Conover C, DeLeon DD, Donovan SM, Ocrant I, Giudice LC: Insulin-like growth factor-binding proteins. Rec Progr Horm Res 46:99-159, 1991
5. Baxter RC, Martin JL: Binding proteins for the insulin-like growth factors: structure, regulation and function. Progr Growth Factor Res 1:49-68, 1989
6. Jones JL, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev 16:3-34, 1995
7. Oh Y, Muller HL, Neely EK, Lamson G, Rosenfeld RG: New concepts in insulin-like growth factor receptor physiology. Growth Regul 3:113-123, 1993
8. Werner H, Woloschak M, Stannard B, Shen-Orr Z, Roberts CT Jr, LeRoith D: The insulin-like growth factor receptor: molecular biology, heterogeneity and regulation. In: LeRoith D (ed) Insulin-like Growth Factors: Molecular and Cellular Aspects. CRC Press, Boca Raton FL, 1991, pp 17-47
9. Lowe L: Biological actions of the insulin-like growth factors. In: LeRoith D (ed) Insulin-like Growth Factors: Molecular and Cellular Aspects. CRC Press, Boca Raton FL, 1991, pp 49-85
10. Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson D, Rosenfeld RG: Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28:619-637, 1995
11. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev 16:3-34, 1995
12. Swisshelm K, Ryan K, Tsuchiya K, Sager R: Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced with retinoic acid. Proc Natl Acad of Sci USA 92:4472-4476, 1995
13. Oh Y, Nagalla SN, Yamanaka Y, Kim H, Wilson L, Rosenfeld RG: Identification and characterization of insulin-like growth factor binding protein (IGFBP)-7: recombinant human mac25 protein specifically binds IGF-I and -II. J Biol Chem 271:30322-30325, 1996
14. Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SAW, Ramasharma K, Marshall M, Li CH: Insulin-like growth factor II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol 3:1701-1709, 1989
15. De Leon DD, Wilson DM, Powers M, Rosenfeld RG: Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors 6:327-336, 1992
16. Furlanetto RW, DiCarlo JN: Somatomedin C receptors and growth effects in human breast cancer cells maintained in long-term culture. Cancer Res 44:2122-2128, 1984
17. Huff KK, Kaufman D, Gabbay KH, Spencer EM, Lippman ME, Dickson RB: Human breast cancer cells secrete an insulin-like growth factor-1-related polypeptide. Cancer Res 46:4613-4619, 1986
18. Westley B, May FEB: IGFs and control of cell proliferation in human breast and other cancers. Reviews on Endocrine-Related Cancer 39:29-34, 1991
19. Baxter RC, Maitland JE, Raisur RL, Reddel R, Sutherland RL: High molecular weight somatomedin-C (IGF-I) from T47D human mammary carcinoma cells: immunoreactivity and bioactivity. In: Spencer EM (ed) Insulin-like Growth Factors/Somatomedins. De Gruyter, Berlin, 1983, pp 615-618
20. Cullen KJ, Smith HS, Hill S, Rosen N, Lippman ME, Yee D: Growth factor mRNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 51:4978-4985, 1991
21. Paik S: Expression of IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Res Treat 22:31-38, 1992
22. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48-53, 1990
23. Bonneterre J, Peyrat JP, Beuscart R, Demaille A: Prognostic significance of insulin-like growth factor receptors in human breast cancer. Cancer Res 50: 6931-6935, 1990
24. Peyrat JP, Bonneterre J: The type 1 IGF receptor in human breast diseases. Breast Cancer Res Treat 22: 59-67, 1992
25. De Leon DD, Bakker B, Wilson DM, Hintz RL, Rosenfeld RG: Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding proteins in human breast cancer cell lines. Biochem Biophys Res Commun 152:398-405, 1988
26. Papa V, Hartmann KKP, Rosenthal SM, Maddux BA, Siiteri PK, Goldfine ID: Progestins induce down regulation of insulin-like growth factor I (IGF-I) receptors in human breast cancer cells: potential autocrine role of IGF-II. Mol Endocrinol 5:709-717, 1991
27. Colletti RB, Roberts JD, Devlin JT, Copeland KC: Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Res 49:1882-1884, 1989
28. Reed MJ, Christodoulides A, Koistinen R, Seppala M, Teale JD, Ghilchik MW: The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxy-androstenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer. Int J Cancer 52:208-212, 1992
29. Pollak MN, Huynh HT, Lefebvre SP: Tamoxifen reduces serum insulin-like growth factor I (IGF-I). Breast Cancer Res Treat 22:91-100, 1992
30. Pollak MN: Effects of adjuvant tamoxifen therapy on growth hormone and insulin-like growth factor I (IGF-I) physiology. In: Salmon SE (ed) Adjuvant Therapy of Cancer VII. Lippincott, 1993, pp 43-53
31. Lamson G, Giudice LC, Rosenfeld RG: Insulin-like growth factor binding proteins: Structural and molecular relationships. Growth Factors 5:19-28, 1991
32. Figueroa JA, Jackson JG, McGuire WL, Krywicki RF, Yee D: Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status. J Cell Biochem 52:196-205, 1993
33. Rosenfeld RG: Somatomedin action and tissue growth-factor receptors. In: Robbins RJ, Melmed S (eds) Acromegaly. Plenum Press, New York, 1987, pp 45-53
34. Neely EK, Beukers WM, Oh Y, Cohen P, Rosenfeld RG: Insulin-like growth factor receptors. Acta Pediatr Scand [Suppl] 372:116-123, 1991
35. Oh Y, Muller HL, Neely EK, Lamson G, Rosenfeld RG: New concepts in insulin-like growth factor receptor physiology. Growth Regul 3:113-123, 1993
36. Hintz RL, Liu F: Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab 45:988-982, 1977
37. Baxter RC, Martin JL, Tayler MI, Howden MEH: Growth hormone-dependent insulin-like growth factor (IGF) binding protein from human plasma differs from other human IGF binding proteins. Biochem Biophys Res Commun 139:1256-1259, 1986
38. Guler HP, Zapf J, Schmid C, Froesch ER: Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) 121:753-758, 1989
39. Baxter RC, Martin JL: Binding proteins for the insulin-like growth factors: structure, regulation, and function. Prog Growth Factor Res 1:49-56, 1989
40. Martin JL, Coverley JA, Pattison ST, Baxter RC: Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: Stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol. Endocrinology 136:1219-1226, 1995
41. Paik S: Expression of IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Res Treat 22:31-38, 1992
42. Pratt SE, Pollak MN: Estrogen and antiestrogen modulation of MCF-7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res 53:5193-5198, 1993
43. Capony F, Rougeot C, Montcourrier P, Cavailles V, Salazar G, Rochefort H: Increased secretion, altered processing and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res 49:3904-3909, 1989
44. Conover CA, De Leon DD: Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D. J Biol Chem 269:7076-7080, 1994
45. Yu H, Diamandis EP, Sutherland DJA: Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clinical Biochem 27:75-79, 1994
46. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG: Prostate specific antigen (PSA) is an IGF binding protein-3 (IGFBP-3) protease found in seminal plasma. J Clin Endocrinol Metab 75:1046-1053, 1993
47. Schmitt M, Goretzki L, Janicke F, Calvete J, Eulitz M, Kobayashi H, Chucholowski N, Graeff H: Biological and clinical relevance of the urokinase-type plasminogen activator in breast cancer. Biomedica Biochimica Acta 50:731-741, 1991
48. Lee DY, Park SK, Yorgin PD, Cohen P, Oh Y, Rosenfeld RG: Alteration of insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure. J Clin Endocrinol Metab 79:1376-1382, 1994.
49. Cohen P, Peehl DM, Lamson G, Rosenfeld RG: Insulin-like growth factors (IGFs), IGF receptors and IGF binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 73:401-407, 1991
50. Lalou C, Lassarre C, Binoux M: A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137:3206-3212, 1996
51. Pratt SE, Pollak MN: Estrogen and antiestrogen modulation of MCF-7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res 53:5193-5198, 1993
52. Pratt SE, Pollak MN: Insulin-like growth factor binding protein 3 (IGFBP-3) inhibits estrogen-stimulated breast cancer cell proliferation. Biochem Biophys Res Commun 198:292-297, 1994
53. Oh Y, Muller HL, Lamson G, Rosenfeld RG: Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem 268:14964-14971, 1993
54. Oh Y, Muller HL, Pham HM, Rosenfeld RG: Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268:26045-26048, 1993
55. Oh Y, Müller HL, Ng L, Rosenfeld RG: TGF-β - induced cell growth inhibition in human breast cancer cells is mediated through IGFBP-3 action. J Biol Chem 270:13589-13592, 1995
56. Gucev ZS, Kelley KM, Rosenfeld RG, Oh Y: Insulin-like growth factor binding protein-3 (IGFBP-3) mediates retinoic acid (RA)- and transforming growth factor-β2 (TGF-β2)-induced growth inhibition in human breast cancer cells. Cancer Res 56:1545-1550, 1996
57. Oh Y, Muller HL, Pham HM, Lamson G, Rosenfeld RG: Non-receptor mediated, post-transcriptional regulation of insulin-like growth factor binding protein (IGFBP)-3 in Hs578T human breast cancer cells. Endocrinology 131:3123-3125, 1992
58. Kraus MH, Yuasa Y, Aaronson SA: A position 12-activated H-ras oncogene in all Hs578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. Biochem 81:5384-5388, 1984
59. Kozma S, Boggard M, Buser K, Saurer S, Bos J, Groner B, Hynes N: The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinorma cell line MDA-MD-231. Nucleic Acids Res 15:5963-5970, 1987
60. Davidson NE, Gelmann EP, Lippman ME, Dickson RB: Epidermal growth factor receptor gene expression in estrogen receptor positive and negative human breast cancer cell lines. Mol Endocrinol 1:216-223, 1987
61. Yamanaka Y, Fowlkes JL, Rosenfeld RG, Oh Y: Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells. J Biol Chem (submitted), 1997
62. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB: Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428, 1987
63. Fontana JA, Burrows-Mezu A, Clemmons DR, LeRoith D: Retinoid modulation of insulin-like growth factor-binding proteins and inhibition of breast carcinoma proliferation. Endocrinology 128:1115-1122, 1990
64. Martin JL, Ballesteros M, Baxter RC: Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. Endocrinology 131:1703-1710, 1992
65. San Roman GA, Magoffin DA: Insulin-like growth factor binding proteins in ovarian follicles from women with polycystic ovarian disease: cellular source and levels in follicular fluid. J Clin Endocrinol Metab 75:1010-1016, 1992
66. Huynh H, Yang X, Pollak M: Estradiol and anti-estrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem 271:1016-1021, 1996
67. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P: The human insulin-like growth factor (IGF) binding protein-3 inhibits cell growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361-367, 1995
68. Delbe J, Blat C, Desauty G, Harel L: Presence of IDF45 (mIGFBP-3) binding sites on chick embryo fibroblasts. Biochem Biophys Res Commun 179:495-501, 1991
69. Andreatta-Van Leyen S, Hembree JR, Eckert RL: Regulation of insulin-like growth factor binding protein 3 levels by epidermal growth factor and retinoic acid in cervical epithelial cells. J Cell Physiol 160:265-274, 1994
70. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N: Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649, 1995
71. Wilson EM, Oh Y, Rosenfeld RG: Generation and characterization of an IGFBP-7 antibody: Identification of 31-kDa IGFBP-7 in human biological fluids and Hs578T human breast cancer conditioned media. J Clin Endocrinol Metab 82:1301-1303, 1997